[1] General Office of National Health Commission,Office of State Administration of Traditional Chinese Medicine,General Office of Logistics Support Department of the Central Military Commission.Notice of Issuing Medical Institution Prescription Auditing Practices[S/OL].(2018-07-10)[2019-07-30].http://www.nhc.gov.cn/yzygj/s7659/201807/de5c7c9116b547af819f825b53741173.shtml. [2] Chinese Pharmacopoeia Commission.Pharmacopoeia of People's Republic of China[M].2015 Edition.Beijing:People's Medical Publishing House (PMPH),2015:1-1608. [3] Ministry of Health.Prescription Administrative Policy[S/OL].(2006-02-14)[2019-07-30].http://www.nhc.gov.cn/yzygj/s3572/200602/dd4277bbf3784ff589b9f12b6a0422ab.shtml. [4] Office of National Health and Family Planning Commission,Office of State Administration of Traditional Chinese Medicine,Drug Equipment Bureau of the Ministry of Health.Notice of Issuing Guiding Principles of Clinical Use of Antibiotics (2015Edition) [S/OL].(2015-08-27)[2019-07-30].http://www.nhc.gov.cn/yzygj/s3593/201508/c18e1014de6c45ed9f6f9d592b43db42.shtml. [5] Ministry of Health.Notice of Issuing Management Practices of Hospital Prescription Comment(Trial) [S/OL].(2010-03-03[2019-07-30].http://www.nhc.gov.cn/yzygj/s3590/201810/6103f922f61440d1b48ba1571b6b6b72.shtml. [6] Wang SB,Fang SP,Zhao YH.Analysis of Medication Order Evaluation in Wards of Our Hospital from 2012 to 2013[J].Herold of Medicine(医药导报),2015,34(s1):146-147. [7] Gao Y,Yang J,Yu BP,et al.Pareto diagram analysis and intervention on irrational prescription in outpatient section of our hospital[J].Chinese Journal of Hospital Pharmacy(中国医院药学杂志),2017,37(2):169-171. [8] Sun NL,Huo Y,Wang JG,et al.Expert Consensus on Diagnosis and Treatment of Resistant Hypertension[J].Chinese Journal of Hypertension(中华高血压杂志),2013,21(4):321-326. [9] Writing Group of 2018 Chinese Guidelines for the Management of Hypertension.2018 Chinese Guidelines for the Management of Hypertension of 2018 Chinese Guidelines for the Management of Hypertension.2018 Chinese Guidelines for the Management of Hypertension[J].Chinese Journal of Cardiovascular Medicine(中国心血管杂志),2019,24(1):24-56. [10] Expert Committee on Rational Drug Use of National Health and Family Planning Commission,Chinese Medical Doctor Association Hypertension Committee.Guidelines for rational drug use in hypertension (2nd Edition)[J].Chinese Journal of the Frontiers of Medical Science (Electronic Version)(中国医学前沿杂志(电子版)),2017,9(7):28-126. [11] Farhat N,Haddad N,Crispo J,et al.Trends in concomitant clopidogrel and proton pump inhibitor treatment among ACS inpatients,2000-2016[J].European Journal of Clinical Pharmacology,2019,75(2):227-235. [12] Chinese Diabetes Society.Chinese guidelines for the prevention and treatment of type 2 diabetes mellitus (2017 edition)[J].Chinese Journal of Diabetes Mellitus(中华糖尿病杂志),2018,10(1):4-67. [13] Mu YM,Ji LN,Ning G,et al.Expert consensus on clinical application of metformin (2018 edition)[J].Chinese Journal of Diabetes(中国糖尿病杂志),2019,27(3):161-173. [14] Wang XT,Zhao X.The relationship between hypercoagulability and cardiovascular events of patients with diabetic nephropathy[J].Chinese Journal of Gerontology(中国老年学杂志),2016,36(1):245-247. [15] Wu LF,Zhuo ST,Lin T,et al.Pareto chart analysis of irrational drug use for 984 inpatients[J].Chinese Journal of Hospital Pharmacy(中国医院药学杂志),2016,36(9):737-740. [16] Chen XQ,Jin YY,Tang G.New Materia Medica[M].17th Edition.Beijing:People's Medical Publishing House (PMPH),2012:87-88. [17] Lu J,Zhen JC.Analysis of Inpatient Medical Prescriptions of Oral Medicines between 2013 and 2016[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2017,14(2):113-115,118. [18] Zhang X,Lu J,Yang SG.Intervention Analysis and Improvement Measures on Irrational Outpatient Prescriptions between 2012 and 2014[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2016,13(2):103-106. |